Sponsor or institution
Clinical trials and research at Tata Memorial Hospital
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Tata Memorial Hospital that are recruiting, at sites in 3 countries (most in India (17), Japan (1), Thailand (1)). By phase: Phase 3 (3), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 3Countries
Newest trials
All recruiting trials (17)
-
Late radiation side effects after postoperative IMRT and brachytherapy for cervical and endometrial cancer
This project will see how often and how severe late gastrointestinal and urinary side effects are in people with cervical or endometrial cancer who received postoperative IMRT and/or brachytherapy at Tata Memorial Hospital.
-
Terbium-161 DOTATATE for metastatic gastro‑enteropancreatic neuroendocrine tumors
This trial tests terbium-161 DOTATATE, a targeted radioactive drug, in adults with metastatic well-differentiated GEP‑NETs who have progressed after lutetium‑177 therapy.
-
Outcomes for Oligometastatic and Oligorecurrent Cervical Cancer
This registry will see if adding local treatments such as radiation or surgery to standard systemic therapy helps people with oligo‑metastatic or oligo‑recurrent cervical cancer live longer or avoid progression.
-
FAPi PET/CT scan for pancreatic ductal adenocarcinoma
This test uses a Gallium-68–labeled FAP inhibitor with PET/CT to see if it can detect tumor tissue and tumor-associated stroma in adults with biopsy-proven pancreatic ductal adenocarcinoma.
-
Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers
This project will check how closely hospitals across India follow recommended chemoradiation treatments for patients with cervical cancer.
-
Asian registry of brachytherapy for cervical cancer
This project will see how different internal radiation (brachytherapy) approaches are used and perform for people in Asia with stage IB–IVA cervical cancer treated with chemoradiation.
-
PRRT alone versus PRRT plus chemotherapy for gastroenteropancreatic neuroendocrine tumors
This test sees if adding capecitabine–temozolomide chemotherapy to Lutetium‑177 DOTATATE PRRT helps adults with advanced gastroenteropancreatic neuroendocrine tumors live longer without the cancer getting worse.
-
Outcomes and quality of life for people with vulvar and vaginal cancer treated with radiation
This project will collect clinical, treatment, and quality-of-life information to see if patterns of relapse and treatment side effects can be identified in people with vulvo-vaginal cancer who receive radiation, with or without chemotherapy or surgery.
-
Immune changes in tumors and blood during pelvic radiotherapy and brachytherapy for cervical cancer.
This project will test whether pelvic radiotherapy, with or without chemotherapy and brachytherapy, changes immune cells and PD-L1 levels in tumors and blood of people with cervical cancer.
-
Spatially fractionated radiation for gynecologic cancers
This will try spatially fractionated radiation after external beam therapy to control cervical cancer or pelvic recurrences in people who can't have standard brachytherapy.
-
Comparing two surgical approaches for early mouth cancers
This study is testing whether a less invasive surgery for early mouth cancers can provide similar survival rates while being easier on patients and more affordable than the standard approach.
-
Comparing maintenance therapy with radiation for lung cancer patients with limited metastases
This study is testing if adding radiation therapy to standard treatment can help lung cancer patients with a few spots of cancer live better and longer.
-
Combining targeted therapy with radiation for specific lung cancer patients
This study is testing if adding radiation therapy to a targeted cancer treatment can help people with a specific type of lung cancer feel better compared to just using the targeted treatment alone.
-
Comparing observation to upfront cranial radiation in patients with specific lung cancer and brain metastases
This study is testing whether giving radiation treatment right away helps people with specific lung cancer and brain metastases live longer and feel better compared to just watching and waiting.
-
High-efficiency platforms for personalized cervix cancer treatment
This project will use past patient imaging and treatment records to build machine-learning tools that predict tumor response and normal tissue side effects for people treated for cervix cancer.
-
Comparing two radiation schedules for advanced cervical cancer treatment
This study is testing whether a quick week-long radiation treatment can help relieve pain better than a longer 6-8 week schedule for patients with advanced cervical cancer who can't have surgery.
-
Optimizing radiation doses for treating diffuse large B-cell lymphoma
This study is testing if a lower radiation dose can effectively treat patients with diffuse large B-cell lymphoma while causing fewer side effects compared to the standard higher dose.
Quick answers
How many clinical trials run by Tata Memorial Hospital are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in India (17 trials), Japan (1 trial), Thailand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.